The prevalence of potential drug-drug interactions in hospital setting: cardiovascular diseases versus comorbidities
Authorized Users Only
2017
Authors
Kovačević, Milena
Vezmar-Kovačević, Sandra

Miljković, Branislava

Radovanović, Slavica
Stevanović, Predrag
Conference object (Published version)

Metadata
Show full item recordSource:
Pharmacotherapy, 2017, 37, 6, e38-e38Publisher:
- Wiley, Hoboken
Note:
- ACCP Virtual Poster Symposium, May 17–18, 2017
Collections
Institution/Community
PharmacyTY - CONF AU - Kovačević, Milena AU - Vezmar-Kovačević, Sandra AU - Miljković, Branislava AU - Radovanović, Slavica AU - Stevanović, Predrag PY - 2017 UR - https://farfar.pharmacy.bg.ac.rs/handle/123456789/2990 PB - Wiley, Hoboken C3 - Pharmacotherapy T1 - The prevalence of potential drug-drug interactions in hospital setting: cardiovascular diseases versus comorbidities VL - 37 IS - 6 SP - e38 EP - e38 DO - 10.1002/phar.1964 ER -
@conference{ author = "Kovačević, Milena and Vezmar-Kovačević, Sandra and Miljković, Branislava and Radovanović, Slavica and Stevanović, Predrag", year = "2017", publisher = "Wiley, Hoboken", journal = "Pharmacotherapy", title = "The prevalence of potential drug-drug interactions in hospital setting: cardiovascular diseases versus comorbidities", volume = "37", number = "6", pages = "e38-e38", doi = "10.1002/phar.1964" }
Kovačević, M., Vezmar-Kovačević, S., Miljković, B., Radovanović, S.,& Stevanović, P.. (2017). The prevalence of potential drug-drug interactions in hospital setting: cardiovascular diseases versus comorbidities. in Pharmacotherapy Wiley, Hoboken., 37(6), e38-e38. https://doi.org/10.1002/phar.1964
Kovačević M, Vezmar-Kovačević S, Miljković B, Radovanović S, Stevanović P. The prevalence of potential drug-drug interactions in hospital setting: cardiovascular diseases versus comorbidities. in Pharmacotherapy. 2017;37(6):e38-e38. doi:10.1002/phar.1964 .
Kovačević, Milena, Vezmar-Kovačević, Sandra, Miljković, Branislava, Radovanović, Slavica, Stevanović, Predrag, "The prevalence of potential drug-drug interactions in hospital setting: cardiovascular diseases versus comorbidities" in Pharmacotherapy, 37, no. 6 (2017):e38-e38, https://doi.org/10.1002/phar.1964 . .